INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE

The INCLUDE Project
CFDA 93.T21 Active Grant Cooperative Agreement

Program Funding

Annual program obligations reported to SAM.gov.

Latest annual funding (estimated)
$87M FY2026
$86.8M
FY24
$87.5M
FY25
$87M
FY26*
* estimated

Funded Projects

Examples of what this program has supported.

FY2025 Fiscal year 2025 competing and noncompeting research project grants were 112. Of this number, 92 were research awards, 11 were training and career development awards, 3 were center awards, 5 were cooperative agreement awards, and 1 was a contract.

Program Objective

The INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project's mission is to investigate conditions that affect individuals with Down syndrome and the general population. Applying the expertise and resources from multiple NIH Institutes and Centers, the INCLUDE Project supports research and research training to achieve the following objectives: (1) Conduct targeted, high-risk, high-reward basic science studies on chromosome 21; (2) Assemble a large study population of individuals with Down syndrome; (3) Conduct clinical trials research inclusive of individuals with Down syndrome.

Eligibility

Eligible Applicants

  • State
  • Local
  • Territorial
  • Tribal
  • U.S. Federal Government
  • Nonprofit Organization
  • For-Profit Organization
  • Other

How to Apply

Award Procedure

Applications are reviewed for scientific and technical merit by a scientific review group and for program relevance by a national advisory council/board. Grants and cooperative agreements are funded based on scientific merit, program relevance, and program balance and are made annually. The initial grant award provides funds for the first budget period (usually 12 months) and letter Notice of Award indicates support recommended for the remainder of the project period, allocation of Federal funds by budget categories and special conditions, if any. Other Transactions are awarded based on the criteria stated within the research opportunity announcement for each initiative.

Decision Timeline

  • Approval: > 180 Days
  • Renewal interval: > 180 Days
Program details & compliance

Description

The INCLUDE Project launched in June 2018 in support of a Congressional directive in the Fiscal Year 2018 Omnibus Appropriations that called for a new NIH-wide research initiative on critical health and quality-of-life needs for individuals with Down syndrome.

This assistance listing supports research activities including, but not limited to, basic science, cohort development, and clinical trial research; development of shared research resources and infrastructure; data harmonization and analysis; career development and training; and community-engaged research approaches. Projects funded under this listing contribute to a comprehensive research portfolio addressing conditions that affect individuals with Down syndrome and the general population, such as Alzheimer’s disease/dementia, autism, cataracts, celiac disease, congenital heart disease and diabetes.

Mission Categories

Primary: General Health and Medical

Required Documentation

Applications must be submitted in compliance with instructions provided with each Notice of Funding Opportunity announcement.

Reporting & Compliance

Audit Required
Yes — Determined at Time of Award
Records Retention
3 years

Applicable 2 CFR 200 Subparts

  • Subpart B — General Provisions
  • Subpart C — Pre-Federal Award Requirements
  • Subpart D — Post-Federal Award Requirements
  • Subpart E — Cost Principles
  • Subpart F — Audit Requirements

Contacts

The INCLUDE Project
301-402-9852
1 Center Drive, Bethesda, MD 20892
Data from SAM.gov Federal Assistance Listings. Source published: 2026-03-17. Spec v2.0. Last synced: 2026-05-28 07:24:05.